TRCT
BDRX

Tower Research Capital (TRC)’s Biodexa Pharmaceuticals BDRX Stock Holding History

Tower Research Capital (TRC)’s Portfolio BDRX Stock Details BDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Hold
0
– -$254 – 5919
2023
Q3 		– Hold
0
– – – 5634
2019
Q4 		– Hold
0
– – – 3547
2019
Q3 		– Hold
0
– – – 4082
2016
Q4 		– Hold
0
– -$3K – 3818
2016
Q3 		– Hold
0
– – – 2814
2016
Q2 		– Hold
0
– – – 3859
2016
Q1 		– Hold
0
– – – 3329
2015
Q4 		– Hold
0
– – – 4024

Other funds holding BDRX

BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return